Related Experiment Video
Updated: May 9, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Novel strategies for the treatment of heart failure
1The Clinical Research Institute at Rambam (CRIR), the Heart Institute, Rambam Medical Center, Haifa, Israel and the Department of Physiology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Insights
New heart failure therapies target cellular and molecular remodeling. These emerging treatments aim to reverse cardiac dysfunction by addressing abnormalities at multiple levels for future clinical use.
Area of Science:
- Cardiology
- Molecular Biology
- Pharmacology
Background:
- Heart failure is a growing global health concern, leading to significant morbidity and mortality.
- Current treatments primarily focus on neurohumoral inhibition and managing fluid overload with diuretics.
- Pathophysiological understanding reveals that cardiac remodeling at cellular and molecular levels drives heart failure progression.
Purpose of the Study:
- To discuss emerging therapeutic strategies for heart failure.
- To highlight novel approaches targeting cellular and molecular remodeling processes.
- To explore interventions addressing receptor function, calcium handling, and extracellular matrix changes.
Main Methods:
- Review of experimental strategies for heart failure treatment.
- Discussion of interventions aimed at correcting cellular and molecular abnormalities.
- Analysis of approaches targeting signaling pathways and excitation-contraction coupling.
Main Results:
- Identification of multiple levels for therapeutic intervention in heart failure.
- Focus on correcting receptor and post-receptor dysfunction.
- Exploration of strategies to modify calcium handling and extracellular matrix.
Conclusions:
- Emerging therapies offer a new paradigm for heart failure treatment by targeting remodeling.
- Novel approaches aim to reverse cardiac dysfunction at cellular and molecular levels.
- These innovative strategies hold promise for future clinical application in managing heart failure.
Abstract:
Heart failure is a leading cause of morbidity and mortality with a prevalence that is rising throughout the world. Currently the pharmaceutical therapy of heart failure is mainly based on inhibition of the neurohumoral pathways that are activated secondary to the deterioration of cardiac function, and diuretics to alleviate the salt and water overload. With our increasing understanding of the pathophysiology of heart failure, it is now clear that the macroscopic and functional changes in the failing heart result from remodeling at the cellular, interstitial, and molecular levels. Therefore, emerging therapies propose to intervene directly in the remodeling process at the cellular and the molecular levels. Here, several experimental strategies that aim to correct the abnormalities in receptor and post-receptor-function, calcium handling, excitation and contraction coupling, signaling, and changes in the extra-cellular matrix in the failing heart will be discussed. These novel approaches, aiming to reverse the remodeling process at multiple levels, may appear on the clinical arena in the coming years.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure Drugs: β-Blockers
